Phathom Pharmaceuticals shares owned by MPM Oncology Impact Management
Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by MPM Oncology Impact Management
from 13F filings
Historical chart of MPM Oncology Impact Management investment in Phathom Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Phathom Pharmaceuticals held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Phathom Pharmaceuticals by MPM Oncology Impact Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $3.6M | 347k | 10.37 |
2023-06-30 | $4.0M | 282k | 14.32 |
2023-03-31 | $1.5M | 213k | 7.14 |
2022-12-31 | $2.2M | 196k | 11.22 |
2022-09-30 | $2.1M | 193k | 11.08 |
2022-06-30 | $1.6M | 193k | 8.44 |
2022-03-31 | $2.6M | 193k | 13.61 |
More positions owned by MPM Oncology Impact Management
View all positions for MPM Oncology Impact Management